WPC 2019 Program

 

 

Click here to download the Provisional Program & Call For Abstracts

Click here to download the Basic Science Program

 You can continue to scroll down the page to view the sessions being offered.

 

 

 Click here to view the Program-At-A Glance for WPC 2019

 


Tuesday, June 4, 2019 - View all Pre-congress Course Details Here

Pre-Congress Course I: Fundamentals of PD: The Journey

Pre-Congress CME Course II: Interdisciplinary and patient centered care for Parkinson's disease

Pre-Congress CME Course III: Advances in research, science & care

Pre-Congress Course IV: Advocacy course: Activism, awareness, and roles patients play

Pre- Congress Course V: Japanese Corporate Track for Health Professionals


Wednesday, June 5, 2019

Hot Topics > 8:00 - 9:00 AM                                                                                同時通訳あり

TBD (based on submitted abstracts) sponsored by American Parkinson Disease Association

Award Ceremony > 9:00 - 9:30 AM                                                                     同時通訳あり

Recipient: TBA

Morning Plenary > 9:30 - 11:30 AM                                                                     同時通訳あり

Alpha-synuclein and Parkinson's

Co-Chair: Glenda Halliday (Australia)

Co-Chair: Serge Przedborski (USA)

Talk 1: What is alpha-synuclein - The biology

Speaker: Ronald Melki (France)

Talk 2: The Pathology of alpha-synucleinopathies (brain donation)

Speaker: Shigeo Murayama (Japan)

Talk 3: Patients as living science: The importance of participating in clinical trials

Speaker: Soania Mathur (Canada)

Talk 4: Clinical trials and efficacy of clinical trials targeting alpha-synuclein

Speaker: Jesse Cedarbaum (USA)


Lunch > 11:30 AM - 1:30 PM


James Parkinson Special Lecture > 12:15 - 1:15 PM                                          同時通訳あり

Mitochondrial energy crisis as a pathogenesis of Parkinson's disease

Introduction by: Roger Barker (UK)

Speaker: Yoshikuni Mizuno (Japan)

Professor Mizuno is the former Chairman of the Department of Neurology at Juntendo University School of Medicine in Tokyo where is now Professor emeritus. Having received his MD from the University of Tokyo School of Medicine in 1965, he completed the residency at the Department of Neurology, Northwestern University Medical Center, Chicago, USA in 1973. He returned to Japan in the same year as Assistant Professor of Neurology at the Jichi Medical School, Tochigi, and served as Professor of Neurology at the Juntendo University School of Medicine from 1989 to 2006. During this time, working with his collaborators, he helped identify the gene (parkin) for the autosomal recessive form of young onset familial Parkinson’s disease.


Parallel Sessions > 1:30 - 3:00 PM

WP1 - Stem Cells in Parkinson's Disease

Co-Chair: Roger Barker (UK)

Co-Chair: Hideki Mochizuki (Japan)

Talk 1: Patient-derived cells to study Parkinson's disease: are astrocytes passive or active players of the disease?

Speaker: Laurent Roybon (Sweden)

Talk 2: Making authentic midbrain dopamine neurons - The challenges

Speaker: Agnete Kirkeby (Denmark)

Talk 3: Translating a stem cell-derived dopamine cell to a clinical drafting trial for PD

Speaker: Azuka Morizane (Japan)

WP2 - Diagnosis, Mechanisms, and Management of Cognitive Deficits in Parkinson's Disease

Co-Chair: Jennifer Goldman (USA)

Co-Chair: Rebecca Miller (USA)

Talk 1: Cognitive Deficits in Parkinson's disease: Clinical features, diagnosis, and evolution

Speaker: Caroline Williams-Gray (UK)

Talk 2: Neuropathology of cognitive deficits in PD and its insights into therapeutic interventions

Speaker: Tom Montine (USA)

Talk 3: Therapeutic programs for cognitive health in PD - interventions and preventions

Speaker: Atsushi Takeda (Japan)

WP3 - Sleep Disorders

Co-Chair: Anne Louise Lafontaine (Canada)

Co-Chair: Simon Lewis (Australia)

Talk 1: An overview of sleep disorders in Parkinson's disease

Speaker: Isabelle Arnulf (France)

Talk 2: The restorative function of sleep 

Speaker: David Breen (UK)

Talk 3: Tips and tricks to managing sleep disorders in Parkinson's

Speaker: Aleksander Videnovic (USA)

[JP1] 司会:渡辺宏久(名古屋大学 脳とこころの研究センター)
大山彦光(順天堂大学脳神経内科)

テーマ:最新のパーキンソン病の診断と治療
トーク1・・・パーキンソン病の新しい診断
演者:澤本伸克(京都大学大学院医学研究科 教授)
トーク2・・・パーキンソン病の最新治療 
演者:下 泰司(順天堂大学脳神経内科) 質疑応答 

テーマ:それぞれの年齢や病期に応じた問題の解決と治療について
トーク3・・・若年患者の抱える問題とその対策(20分)
演者:秋山智(広島国際大学看護学部 教授)
トーク4・・・病期や年齢に応じた患者との関わり方について 
演者:高橋裕秀(みどり野リハビリテーション病院パーキンソン病治療センター センター長)
質疑応答 


Workshops > 1:30 - 3:00 PM

WW1 - Selective Neuronal Vulnerability:
What we can and cannot learn about pathogenesis of PD using models

Co-Chair: Etienne Hirsch (France)

Co-Chair: Jeffrey Kordower (USA)

Talk 1: Developmental genes lay the foundation for neurodegeneration in PD

Speaker: Ernest Arenas (Sweden)

Talk 2: The role of cellular thresholds in driving selective neuronal vulnerability of PD

Speaker: David Sulzer (USA)

Talk 3: The role of neural circuits in PD

Speaker: To be announced

WW2 - Wearable Apps for Monitoring PD and its treatment

Co-Chair: Elena Moro (France)

Co-Chair: Peter LeWitt (USA)

Talk 1: State of the art of wearable devices in Parkinson's disease

Speaker: Joachim Ferreira (Portugal)

Talk 2: Applications of wearable devices in clinical trials

Speaker: Tanya Simuni (USA)

Talk 3: "Wearables" for monitoring PD and its treatment

Speaker: Walter Maetzler (Germany)

WW3 - Levodopa and Dopamine Agonists:
How to find a balance between the good and the not so good

Co-Chair: Angela Cenci-Nilsson (Sweden)

Co-Chair: Andy McDowell (New Zealand)

Talk 1: The history of levodopa and dopamine agonists - Benefits and myths

Speaker: Stanley Fahn (USA)

Talk 2: Learn how to recognize and manage L-dopa induced dyskinesias

Speaker: Masahiko Tomiyama (Japan)

Talk 3: To learn how to recognize and manage impulse control disorders and dopa-dysregulation syndrome

Speaker: Annette Hand (UK)


Roundtables  > 1:30 - 3:00 PM                                        *マークには日本語でのサポートあり

WRT 1 - Sponsored by American Parkinson Disease Association

Round Table 1: Coping day to day: Managing the emotional roller coaster

Lissa Kapust (USA)

Round Table 2: Tips on getting your research published

Elena Becker-Barroso (UK)

Round Table 3: Insights into the function of LRRK2 from a genetic point of view

Matt Farrer (Canada)
(Translator: Hajime Terao)

Round Table 4: LRRK2 and PD

Jie Shen (USA)

Round Table 5: Combined pharmacotherapy and neuromodulation approaches to PD

John Rothwell (USA)

Round Table 6: Effectiveness and reliability of TMS treatment, new methods and future perspectives

Angelo Quartarone (Italy)
(Translator: Masanobu Ishio)

Round Table 7: What is alpha-synuclein - The biology

Ronald Melki (France)
(Translator: Atsushi Naito)

Round Table 8: Pathological features of alpha-synucleinopathies

Shigeo Murayama (Japan)

Round Table 9: The importance of participating in clinical trials

Soania Mathur (Canada)

Round Table 10: Approaches to voice training in PD

Darla Freeman (USA)

Round Table 11: How PD affects sexuality and Intimacy of PwPD and their care-partners?

Sheila Silver (USA)

Round Table 12: Planet Patient vs Planet Researcher: How do we align instead of collide?

Simon Stott (UK) & A.C. Woolnough (USA)
(Translator: Hisashi Kamido)


Coffee Break > 3:00 - 3:30 PM


Parallel Sessions > 3:30 - 5:00 PM

WP4 - LRRK2 and Its Relationship to Endosomal Biology

Co-Chair: Mark Cookson (USA)

Co-Chair: Anthony Schapira (UK)

Talk 1: LRRK2 and its relationship to endosomal biology

Speaker: Matt Farrer (Canada)

Talk 2: LRRK2 in Dopaminergic Neuronal Survival and Parkinson's Disease

Speaker: Jie Shen (USA)

Talk 3: LRRK2 as a therapeutic target

Speaker: Brian Fiske (USA)

WP5 - The Microbiome and Diet in Parkinson's disease

Co-Chair: Marie-Francoise Chesselet (USA)

Co-Chair: Frank Church (USA)

Talk 1: The vermiform appendix contributes to the development of Parkinson's disease

Speaker: Viviane Labrie (USA)

Talk 2: What is the evidence for, and the relevance of, GIT pathology in PD?

Speaker: Pascal Derkinderen (France)

Talk 3: Is there any evidence that nutrients modify PD?

Speaker: Laurie Mischley (USA)

WP6 - Depression, Anxiety, and Apathy in PD - Part 1

Co-Chair: Shen Yang Lim (Malaysia)

Co-Chair: Jon Stamford (UK)

Talk 1: Understanding apathy: what it is, what it is not and its impact on disease

Speaker: Kathy Dujardin (France)

Talk 2: Anxiety in Parkinson's disease - symptoms, frequency, and neurobiology

Speaker: Roseanne Dobkin (USA)

Talk 3: Understanding depression in Parkinson's disease - Symptoms, frequency, and neurobiology

Speaker: Murat Emre (Turkey)

テーマ:DBS及びDevice aided therapy

司会:髙橋良輔(京都大学大学院 医学研究科臨床神経学 教授)
服部信孝(順天堂大学脳神経内科 教授)

演者:梅村淳(順天堂大学運動障害疾患病態研究治療講座)(15分)

戸田弘紀(福井赤十字病院脳神経外科)   (15分)

木村活生(横浜市立大学附属市民総合医療センター神経内科) (15分)

大山彦光(順天堂大学脳神経内科)   (15分)

小倉眞一郎(患者、全国パーキンソン病友の会神奈川県支部)  (5分)

伊藤克義(患者、全国パーキンソン病友の会京都府支部 支部長)(5分)

ディスカッション 20分


Workshops > 3:30 - 5:00 PM

WW4 - Transcranial magnetic stimulation in Parkinson's disease: from basic to clinical research

Co-Chair: Paolo Calabresi (Italy)

Co-Chair: Stephane Lehericy (France)

Talk 1: Deciphering transcranial magnetic stimulation mechanisms in early and late experimental parkinsonism

Speaker: Veronica Ghiglieri (Italy)

Talk 2: Combined pharmacotherapy and neuromodulation approaches to PD

Speaker: John Rothwell (UK)

Talk 3: Effectiveness and reliability of TMS treatment, new methods and future perspectives

Speaker: Angelo Quartarone (Italy)

WW5 - How to distinguish fake from real scientific and clinical advances

Co-Chair: Jonathan Kimmelman (Canada)

Co-Chair: Simon Stott (UK)

Talk 1: How do journals decide what to publish and promote?

Speaker: Elena Becker-Barroso (UK)

Talk 2: How does the media choose stories and sell them?

Speaker: Jon Palfreman (USA)

Talk 3: How do you assess all the information that is out there?

Speaker: Benjamin Stecher (Canada)

WW6 - Sexuality and intimacy in Parkinson's for people with Parkinson's and their partners

Co-Chair: Victor McConvey (Australia)

Co-Chair: Lucie Lachance (Canada)

Talk 1: How PD affects sexuality and intimacy of PwP and their care partners? 

Speaker: Sheila Silver (USA)

Talk 2: Medical and non-medical management  of sexual problems in PD

Speaker: Jim Bender (The Netherlands)

Talk 3: How to communicate on sexual issues with my inter-professional team

Speaker: Gila Bronner (Israel)


Roundtables  > 3:30 - 5:00 PM                                        *マークには日本語でのサポートあり 

WRT 2

Round Table 1: Sleep & PD: Tips and tricks

Aleksander Videnovic (USA)

Round Table 2: Therapeutic programs for cognitive health in PD

Atsushi Takeda (Japan)

Round Table 3: Cognitive deficits in Parkinson's disease: Clinical features, diagnosis, and evolution

Caroline Williams-Gray (UK)

Round Table 4: The challenges of making authentic dopamine neurons from stem cells

Agnete Kirkeby (Denmark)

Round Table 5: Translating stem cell therapies to the clinic for trialing 

Azuka Morizane (Japan)

Round Table 6: The role of cellular thresholds in selective neuronal vulnerability in PD

David Sulzer (USA)
(Translator: Shinya Yamashita)

Round Table 7: The history of levodopa and dopamine agonists, benefits and myths

Stanley Fahn (USA)

Round Table 8: Living well with Parkinson's: What's the secret?

Kat Hill (USA) & Nancy Peate (USA) 

Round Table 9: Alpha-synuclein and the immune response in PD

Ashley Harms (USA)
(Translator: Kyohei Kitamura)

Round Table 10: Mechanisms underlying impulsive behaviors and addictions in Parkinson's disease

Christelle Baunez (France)

Round Table 11: Diagnosed with PD . . . Now what?

Andy McDowell (New Zealand)

Round Table 12: Managing dyskinesias

Masahiko Tomiyama (Japan)


Daily > 5:15 - 6:30 PM

WWU - Daily Wrap-Up Panels WPT - Poster Tours
同時通訳あり

Chair: TBD

Panelist 1: Jennifer Goldman (USA)

Panelist 2: Angela Cenci-Nilsson (Sweden)

Panelist 3: Frank Church (USA)

Panelist 4: Paolo Calabresi (Italy)

Panelist 5: Ryosuke Takahashi (Japan)

Guides:

Poster Tour 1: TBD - Laurent Roybon (Sweden)

Poster Tour 2: TBD - David Breen (UK)

Poster Tour 3: TBD - Ashley Harms (UK)

Poster Tour 4: TBD - Tom Montine (USA)

Poster Tour 5: TBD - Glenda Halliday (Australia)

Poster Tour 6: TBD - Angelo Quartarone (Italy)

Poster Tour 7: Wearable Devices - Tanya Simuni (USA)

Poster Tour 8: TBD - Nicolas Dzamco (Australia)

Poster Tour 9: TBD - Isabelle Arnulf (France)

Poster Tour 10: TBD - Simon Stott (UK)


Thursday, June 6, 2019

Hot Topics > 8:00 - 9:00 AM                                                                              同時通訳あり

TBD (based on submitted abstracts) sponsored by American Parkinson Disease Association

Award Ceremony > 9:00 - 9:30 AM                                                                   同時通訳あり

Recipient: TBA

Morning Plenary > 9:30 - 11:30 AM                                                                   同時通訳あり

Are we moving towards personalized medicine?

Co-Chair: Etienne Hirsch (France)

Co-Chair: Ryosuke Takahashi (Japan)

Talk 1: Heterogeneity of Parkinson's disease

Speaker: Connie Marras (Canada)

Talk 2: How are the genetics of Parkinson's disease influencing treatment development?

Speaker: Anthony Schapira (UK)

Talk 3: New trial approaches to treating Parkinson's disease

Speaker: Oliver Rascol (France)

Talk 4: What's it like to live with a gene for Parkinson's disease?

Speaker: Benjamin Stecher (Canada)


Lunch > 11:30 AM - 1:30 PM


Living well with Parkinson's disease: What's your secret?                              同時通訳あり

> 12:15 - 1:15 PM

Chair: Raj Pahwa (USA)

Panelist 1: Omotola Thomas (UK/Nigeria)

Panelist 2: Yoshiko Okada (Japan)

Panelist 3: Emma Lawton (UK)

Panelist 4: Elisabeth Ildal (Denmark)

Panelist 5: Benjamin Stecher (Canada)


Parallel Sessions > 1:30 - 3:00 PM

TP1 - Basal Ganglia Oscillations and Circuitry in Parkinson's Disease

Co-Chair: Elena Moro (France)

Co-Chair: Barbara Picconi (Italy)

Talk 1: Abnormal neural activities in the cortico-basal ganglia networks in animal models of PD

Speaker: Atsushi Nambu (Japan)

Talk 2: Optogenetic modulation of basal ganglia activity in Parkinsonian models

Speaker: Stella Papa (USA)

Talk 3: Adaptive brain stimulation for the treatment of PD: Where are we with this?

Speaker: Alberto Priori (Italy)

TP2 - The Major Discoveries in Parkinson's Over the Last 10 Years

Co-Chair: Tim Anderson (New Zealand)

Co-Chair: Daniel Weintraub (USA)

Talk 1: Alpha-synuclein: A story of accumulation and spread

Speaker: Maria Grazia Spillantini (UK)

Talk 2: Preclinical and prodromal PD: Predictive and risk factors

Speaker: Walter Maetzler (Germany)

Talk 3: iPS and PD

Speaker: Jun Takahashi (Japan)

TP3 - End of Life Planning and Care for Parkinsonism

Co-Chair: Julie Carter (USA)

Co-Chair: Anne Louise Lafontaine (Canada)

Talk 1: State of the art of palliative care in Parkinson's disease: A global perspective

Speaker: Victor McConvey (Australia)

Talk 2: Palliative care in your hands: Advance care planning in parkinsonian disorders

Speaker: Roongroj Bhidayasiri (Thailand)

Talk 3: Case studies in palliative care for parkinsonian disorders

Speaker: Barry Snow (New Zealand)

TP4 - Why Do People with Parkinson's Fall and Can Falls be Prevented?

Co-Chair: Laurie King (USA)

Co-Chair: Jillian Carson (Canada)

Talk 1: Can we predict falls?

Speaker: Colleen Canning (Australia)

Talk 2: Factors that contribute to falls

Speaker: Anat Mirelman (Israel)

Talk 3: Solutions to minimize falls

Speaker: Lynn Rochester (UK)


Workshops > 1:30 - 3:30 PM

TW1 - The Role of Inflammation and the Immune System in Parkinson's Disease

Co-Chair: David Standaert (USA)

Co-Chair: Caroline Williams-Gray (UK)

Talk 1: Alpha-synuclein and the immune response in PD

Speaker: Ashley Harms (USA)

Talk 2: Enhancing clearance of alpha-synuclein by immune related cells for neuroprotection

Speaker: Nadia Stefanova (Austria)

Talk 3: LRRK2 in the Immune System

Speaker: Nicolas Dzamco (Australia)

TW2 - Pain and Parkinson's Disease

Co-Chair: Jon Stoessl (Canada)

Co-Chair: Karen Raphael (USA)

Talk 1: Pain syndromes occurring in Parkinson's disease: Presentations and assessment

Speaker: Santiago Perez-Lloret (Argentina)

Talk 2: Current understanding of underlying mechanisms of pain syndromes in PD

Speaker: TBD

Talk 3: Treatment approaches and clinical trials for pain in PD

Speaker: Beom Jeon (South Korea)

TW3 - YOPD: It's Not All About the Symptoms - Other Life Considerations

Co-Chair: Soania Mathur (Canada)

Co-Chair: Heather Kennedy (USA)

Talk 1: Diagnosed with YOPD - Next steps

Speaker: Andy McDowell (New Zealand)

Talk 2: Tips and tricks for maintaining work/life balance

Speaker: Rebecca Miller (USA)

Talk 3: PD is in the house - Impact on children/teens/young adults

Speaker: Elaine Book (Canada)


Roundtables  > 1:30 - 3:00 PM                                       *マークには日本語でのサポートあり

TRT 1

Round Table 1: Living well with young-onset Parkinson's

Tim Hague (Canada)
(Translator: Masataka Hirai)

Round Table 2: Inflammation, microbiome and PD: What is all the fuss about?

Vivian Labrie (USA)

Round Table 3: Is there any evidence that nutrients modify PD?

Laurie Mischley (USA)
(Translator: Akemi)

Round Table 4: LRRK2 as a therapeutic target

Brian Fiske (USA)

Round Table 5: I have Parkinson's and I care about my genetics: You should too

Martin Taylor (UK)

Round Table 6: Gut microbiota: Putting the puzzle together

Filip Scheperjans (Finland)

Round Table 7: Experimental pharmacological treatments for Parkinson's disease: Discovery of mGlu4 PAMS

Jeff Conn (USA)

Round Table 8: The challenge of disease classification

Rejko Krüger (Luxembourg)

Round Table 9: What is alpha-synuclein and what goes wrong with it in PD

Jeffery Kordower (USA)

Round Table 10: LRRK2 and Parkinson's

Mark Cookson (USA)

Round Table 11: How do you find a good "druggable" candidate in the lab?

Erwan Bezard (France)

Round Table 12: Stem cell tourism - Why is it dangerous?

Jonathan Kimmelman (Canada)


Coffee Break > 3:00 - 3:30 PM


Parallel Sessions > 3:30 - 5:00 PM

TP5 - The Proteinopathy of Parkinson's Disease and its Role in Pathogenesis

Co-Chair: Serge Przedborski (USA)

Co-Chair: Ronald Melki (France)

Talk 1: Synuclein and its role at the synapse

Speaker: Robert Edwards (USA)

Talk 2: The links between mitochondrial failure and lysosomal dysfunction with alpha-synuclein aggregation

Speaker: Dimitri Krainc (USA)

Talk 3: PINK1, Parkin and the ubiquitin system

Speaker: Noriyuki Matsuda (Japan)

TP6 - Advancing Research, Clinical Trials and Real-World Data

Co-Chair: Simon Lewis (Australia)

Co-Chair: Jasmine Sturr (USA)

Talk 1: Where are we with clinical trials right now in PD?

Speaker: Tom Foltynie (UK)

Talk 2: What is it like to be the patient in a clinical trial?

Speaker: Richard Windle (UK)

Talk 3: Using real-world data as an alternative to clinical trials

Speaker: Bas Bloem (The Netherlands)

TP7 - Important Non-Motor Symptoms that are Often Overlooked

Co-Chair: Lucie LaChance (Canada)

Co-Chair: Hirohide Takahashi (Japan)

Talk 1: Evaluating and managing sexual dysfunction in PD

Speaker: Sharon Hassin-Baer (Israel)

Talk 2: Urological dysfunction in PD - What is it and what can be done about it?

Speaker: Ryuji Sakakibara (Japan)

Talk 3: Managing orthostatic hypotension in PD

Speaker: Stuart Isaacson (USA)

TP8 - Strategies to Optimize Daily Living in PwP: Physical, Occupational and Speech Therapies

Co-Chair: Lee Dibble (USA)

Co-Chair: Jennifer Cody (USA)

Talk 1: Can we predict (and therefore minimize) falls in PD?

Speaker: Lynn Rochester (UK)

Talk 2: Facial Masking: What are the social implications?

Speaker: Hanneke Kalf (The Netherlands)

Talk 3: Impact of early training to improve vocalization in PD

Speaker: Michelle Troche (USA)


Workshops > 3:30 - 5:00 PM

TW4 - Advancing the Pharmacology of Parkinson's disease

Co-Chair: Kalpana Merchant (USA)

Co-Chair: Oliver Rascol (France)

Talk 1: Experimental pharmacological treatments for Parkinson's disease: Discovery of mGlu4 PAMS

Speaker: Jeff Conn (USA)

Talk 2: New insights into L-Dopa induced dyskinesias

Speaker: Barbara Picconi (Italy)

Talk 3: Mechanisms underlying impulsive behaviors and addictions in Parkinson's disease

Speaker: Christelle Baunez (France)

TW5 - The Role of Genetics and Genetic Testing in PD

Co-Chair: Susanne Schneider (Germany)

Co-Chair: Martin Taylor (UK)

Talk 1: The role of genetics in increasing our understanding of the pathopysiology of PD

Speaker: John Hardy (UK)

Talk 2: Genetic testing in PD - What is possible and why is it important?

Speaker: Vincenzo Bonifati (The Netherlands)

Talk 3: Ethical and legal aspects of genetic testing in PD

Speaker: Yann Joly (Canada)

TW6 - Music & Dance for Parkinson's Disease

Co-Chair: Terry Ellis (USA)

Co-Chair: David Leventhal (USA)

Talk 1: Dance as exercise for Parkinson's disease

Speaker: Meg Morris (Australia)

Talk 2: The effects of music on the brain

Speaker: Jeanette Tamplin (Australia)

Talk 3: Why partnered dance might optimize motor and cognitive rehabilitation in Parkinson's

Speaker: Madeleine Hackney (USA)


Roundtables  > 3:30 - 5:00 PM                                        *マークには日本語でのサポートあり

TRT 2

Round Table 1: Palliative Care is in your hands

Roongroj Bhidayasiri (Thailand)

Round Table 2: iPS cells and PD - What does this mean in 2019?

Jun Takahashi (Japan)

Round Table 3: Predicting who will get Parkinson's disease

Isabelle Arnulf (France)
(Translator: Ryo Nakanishi)

Round Table 4: Shining a light on Parkinsons: Optogenetic modulation of basal ganglia activity

Stella Papa (USA)
(Translator: Sakura Ikeda)

Round Table 5: Treatment approaches and clinical trials for pain in PD

Beom Jeon (South Korea)
(Translator: Ryutaro Nakagawa)

Round Table 6: The heterogeneity of Parkinson's disease - What does it mean and why is it important

Connie Marras (Canada)
(Translator: Seigi Oshima)

Round Table 7: Maintaining balance and optimism when working  and raising children with young onset PD

Rebecca Miller (USA)
(Translator: Kanako Okamoto)

Round Table 8: Parkinson's and the gut microbiome

Haydeh Payami (USA)

Round Table 9: Measuring gut function in PD

Kathleen Shannon (USA)

Round Table 10: Is inflammation important in PD?

David Standaert (USA)

Round Table 11: New causative genes for PD

Alexis Brice (France)

Round Table 12: Is there a Parkinson's diet?

Karin Overbeek (The Netherlands)


Daily > 5:15 - 6:30 PM

TWU - Daily Wrap-Up Panels TPT - Poster Tours
同時通訳あり

Chair: Serge Przedborski (USA)

Panelist 1: Tim Anderson (New Zealand)

Panelist 2: Roger Barker (UK)

Panelist 3: Julie Carter (USA)

Panelist 4: Anthony Schapira (UK)

Panelist 5: Carolyn Sue (Australia)

Guides:

Poster Tour 1: TBD - Malu Tansey (USA)

Poster Tour 2: TBD - Lucie LaChance (Canada)

Poster Tour 3: Nutrition & diet - Karin Overbeek (The Netherlands)

Poster Tour 4: Exercise, balance, and falls - Margaret Mak (Hong Kong)

Poster Tour 5: TBD - Anne Louise Lafontaine (Canada)

Poster Tour 6: TBD - Aletta D. Kraneveld (The Netherlands)

Poster Tour 7: TBD - Maria Grazia-Spillantini (UK)

Poster Tour 8: TBD - Susanne Schneider (Germany)

Poster Tour 9: TBD - Hirohide Takahashi (Japan)

Poster Tour 10: TBD - Lucilla Parnetti (Italy)


Friday, June 7, 2019

Hot Topics > 8:00 - 9:00 AM                                                                                  同時通訳あり

TBD (based on submitted abstracts) sponsored by American Parkinson Disease Association

Award Ceremony > 9:00 - 9:30 AM                                                                       同時通訳あり

Recipient: TBA

Morning Plenary > 9:30 - 11:30 AM                                                                      同時通訳あり

The peripheral aspects of Parkinson's disease - It is not just a brain disease!

Co-Chair: Hideki Mochizuki (Japan)

Co-Chair: TBD 

Talk 1: Your radical new life: Creative ways to overcome our challenges

Speaker: Heather Kennedy (USA)

Talk 2: Overview of peripheral (non-brain/CNS) abnormalities in PD

Speaker: Jeffrey Kordower (USA)

Talk 3: Does PD start outside the brain?

Speaker: Per Borghammer (Denmark)

Talk 4: Managing of the peripheral problems in PD

Speaker: Shen Yang Lim (Malaysia)


Lunch > 11:30 AM - 1:30 PM


Special Lecture > 12:15 - 1:15 PM                                                                        同時通訳あり

Cellular Reprogramming - What does it mean for the future of medicine?

Introduction by: Yoshikuni Mizuno (Japan)

Speaker: Shinya Yamanaka (Japan),
                2012 Nobel laureate in Physiology or Medicine
Professor Yamanaka won the Nobel prize for the discovery that mature cells can be reprogrammed to become pluripotent. 
He studied for his medical degree at Kobe University and later earned his PhD from Osaka City University in 1993. After spending several years at the Gladstone Institute at the University of California, San Francisco, he returned to Osaka, but later moved to the Nara Institute of Science and Technology, where he began his Nobel Prize-awarded research. Shinya Yamanaka has been affiliated with Kyoto University since 2004.

 


Parallel Sessions > 1:30 - 3:00 PM

FP1 - The GI Tract, Microbiome and Parkinson's

Co-Chair: Malu Tansey (USA)

Co-Chair: Pascal Derkinderen (France)

Talk 1: Gut microbiota, 1013 new pieces in the Parkinson's disease puzzle

Speaker: Filip Scheperjans (Finland)

Talk 2: Parkinson's disease and Parkinson's disease medications have distinct signatures with respect to the gut microbiome

Speaker: Haydeh Payami (USA)

Talk 3: Measuring GI function in Parkinson's disease

Speaker: Per Borghammer (Denmark)

FP2 - New Therapies and Emerging Therapies in PD

Co-Chair: Kalpana Merchant (USA)

Co-Chair: Raj Pahwa (USA)

Talk 1: Immune therapies for PD

Speaker: Seung Jae Lee (Korea)

Talk 2: New surgery for PD

Speaker: Binit Shah (USA)

Talk 3: Repurposing drugs for PD

Speaker: Michael Schwarzschild (USA)

FP3 - Is There a "Best" Exercise for Parkinson's Disease?

Co-Chair: Joaquim Ferreira (Portugal)

Co-Chair: Laurie King (USA)

Talk 1: Aerobic exercise for PD

Speaker: Terry Ellis (USA)

Talk 2: Strengthening exercise for PD

Speaker: Lee Dibble (USA)

Talk 3: Complex balance training for PD

Speaker: Margaret Mak (Hong Kong)

 


Workshops > 1:30 - 3:00 PM

FW1 - The Role of Aging in Parkinson's Disease

Co-Chair: Glenda Halliday (Australia)

Co-Chair: Maria Grazia Spillantini (UK)

Talk 1: Aging of the immune system and relevance to brain health and disease

Speaker: V. Wee Yong (Canada)

Talk 2: Proteostasis, molecular chaperones and aging - Implications for PD

Speaker: Heath Ecroyd (Australia)

Talk 3: Aging mitochondrial function and bioenergetics - What does this mean for PD pathogenesis?

Speaker: Carolyn Sue (Australia)

FW2 - What is the Best Biomarker in Parkinson's Disease

Co-Chair: Brian Fiske (USA)

Co-Chair: Jean Burns (USA)

Talk 1: The use of neuroimaging as a biomarker in PD

Speaker: Stephane Lehericy (France)

Talk 2: The current status of "wet" biomarkers (blood, CSF, etc) as a biomarker in PD

Speaker: Lucilla Parnetti (Italy)

Talk 3: Could biopsies from outside the brain help in the diagnosis and tracking of PD?

Speaker: Kathleen Shannon (USA)

FW3 - The Voice and Respiration in PD

Co-Chair: Hanneke Kalf (The Netherlands)

Co-Chair: Jeanette Tamplin (Australia)

Talk 1: Overview of voice and breathing in Parkinson's disease

Speaker: Michelle Troche (USA)

Talk 2: Approaches to voice training in PD

Speaker: Darla Freeman (USA)

Talk 3: Maintenance of intelligibility after speech therapy in PD

Speaker: Jennifer Cody (USA)


Roundtables  > 1:30 - 3:00 PM                                        *マークには日本語でのサポートあり

FRT 1

Round Table 1: What is left to be discovered in PD?

Tim Anderson (New Zealand)

Round Table 2: Where are we with clinical trials in PD in 2019?

Tom Foltynie (UK)

Round Table 3: What is it like to be a patient in a clinical trial?

Richard Windle (UK)

Round Table 4: Using real world data as an alternative to clinical trials

Bas Bloem (The Netherlands)
(Translator: Hisashi Kamido)

Round Table 5: Molecular advances in stem cell and reprogramming strategies to treat PD

Ernest Arenas (Sweden)
(Translator: Shinya Yamashita)

Round Table 6: Pain and PD: Patient reality and what we know

Karen Raphael (USA)

Round Table 7: The role of genetics in better understanding the pathophysiology

John Hardy (UK)
(Translator: Seigi Oshima)

Round Table 8: Insulin resistance, diabetes and Parkinson's disease

Dilan Athauda (UK)

Round Table 9: The links between mitochondrial failure and lysosomal dysfunction and alpha-synuclein aggregation

Dimitri Krainc (USA)

Round Table 10: PINK1, parkin and the ubiquitin system - How do they link to what goes wrong in PD

Noriyuki Matsuda (Japan)

Round Table 11: Medical and non-medical management of sexual problems in PD

Jim Bender (The Netherlands)

Round Table 12: Building a one-stop-shop for Parkinson's: Where to start?

Jillian Carson (Canada)
(Translator: Takaaki Yakushigawa)


Coffee Break > 3:00 - 3:30 PM


Parallel Sessions > 3:30 - 5:00 PM

FP4 - Metabolism, Stress, and Parkinson's Disease

Co-Chair: Tom Foltynie (UK)

Co-Chair: Marie-Francoise Chesselet (USA)

Talk 1: PARIS: The Rosetta Stone to Understanding Parkinson's Disease

Speaker: Ted Dawson (USA)

Talk 2: Insulin resistance, diabetes and Parkinson's disease - How do they link together?

Speaker: Dilan Athauda (UK)

Talk 3: Glial and immune basis of chronic stress-induced neurodegeneration in Parkinson's disease

Speaker: Stéphane Hunot (France)

FP5 - How do you take a therapy from the lab, to the clinic, to the market?

Co-Chair: Atsushi Takeda (Japan)

Co-Chair: Stuart Isaacson (USA)

Talk 1: How do you find a good candidate in the lab?

Speaker: Erwan Bezard (France)

Talk 2: How do you take a therapy from the lab, to the clinic, to the market?

Speaker: Kalpana Merchant (USA)

Talk 3: How to move from a first in human study to a marketable drug?

Speaker: Jesse Cedarbaum (USA)

FP6 - The Ins and Outs of Eating in Parkinson's Disease

Co-Chair: Hanneke Kalf (The Netherlands)

Co-Chair: Laurie Mischley (USA)

Talk 1: How to get food & liquid in despite swallowing problems?

Speaker: Sonoko Nozaki (Japan)

Talk 2: Is there a Parkinson's diet?

Speaker: Karin Overbeek (The Netherlands)

Talk 3: Food for thought: The gut-immune-brain axis in Parkinson's disease

Speaker: Aletta D. Kraneveld (The Netherlands)


Workshops > 3:30 - 5:00 PM

FW4 - Neurogenetics in Parkinson's Disease: From Monogeneic Forms of PD to Susceptible Genes for Sporadic Forms of the Disease

Co-Chair: Matt Farrer (Canada)

Co-Chair: Nobutaka Hattori (Japan)

Talk 1: New causative genes for PD

Speaker: Alexis Brice (France)

Talk 2: Next generation sequencing strategies and its role in identifying genetic risk factors for Parkinson's disease

Speaker: Tatsushi Toda (Japan)

Talk 3: The challenge of disease classification in PD - What does it look like and what does it mean?

Speaker: Rejko Krüger (Luxembourg)

FW5 - Stem cells in Parkinson's Disease

Co-Chair: Roger Barker (UK)

Co-Chair: Agnete Kirkeby (Denmark)

Talk 1: Stem cell and reprogramming strategies to treat PD

Speaker: Ernest Arenas (Sweden)

Talk 2: Using stem cells to treat PD

Speaker: Jun Takahashi (Japan)

Talk 3: Stem cell tourism - What is it all about?

Speaker: Jonathan Kimmelman (Canada)

FW6 - Depression, Anxiety, and Apathy in PD: How to Best Manage it - Part 2

Co-Chair: Shen Yang Lim (Malaysia)

Co-Chair: Jon Stamford (UK)

Talk 1: Apathy: Is there a treatment?

Speaker: Kathy Dujardin (France)

Talk 2: Anxiety: How best to manage it

Speaker: Roseanne Dobkin (USA)

Talk 3: Depression: How best to treat it

Speaker: Murat Emre (Turkey)


Roundtables  > 3:30 - 5:00 PM                                        *マークには日本語でのサポートあり

FRT 2

Round Table 1: Abnormal neural activities in the cortico-basal ganglia networks in animal models of PD

Atsushi Nambu (Japan)

Round Table 2: Immune therapies for PD

Seung Jae Lee (Korea)

Round Table 3: Repurposing drugs that target risk factors  for PD

Michael Schwarzschild (USA)

Round Table 4: Why partnered dance is a valuable therapy for people with Parkinson's

Madeleine Hackney (USA)

Round Table 5: Aerobic exercise for Parkinson's disease - Useful or not?

Terry Ellis (USA)
(Translator: Miho Sakai)

Round Table 6: New Insights into L-Dopa induced dyskinesias

Barbara Picconi (Italy)

Round Table 7: Aging of the immune system and its relevance to brain health and PD

V. Wee Yong (Canada)
(Translator: Narumi Saito)

Round Table 8: Medical and surgical advances in Parkinson's

Genko Oyama (Japan)

Round Table 9: A family affair: Well-being for everyone when a diagnosis of PD knocks on the door

Jasmine Sturr (USA)
(Translator: Kanako Okamoto)

Round Table 10: Music & dance for Parkinson's disease

Meg Morris (Australia)
(Translator: Atsushi Naito)

Round Table 11: Sexual intimacy and Parkinson's

Gila Bronner (Israel)

Round Table 12: Where are we with DBS?

Elena Moro (France)


Daily > 5:15 - 6:15 PM                                                                                             同時通訳あり

FWU - Daily Wrap-Up Panels

Chair: Jon Stoessl (Canada)

Panelist 1: Ted Dawson (USA)

Panelist 2: Joaquim Ferreira (Portugal)

Panelist 3: Susanne Schneider (Germany)

Panelist 4: Annette Hand (UK)

Panelist 5: Nobutaka Hattori (Japan)


1359 Broadway
Suite 1509
NY, NY 10018 USA
info@worldpdcoalition.org
646-388-7688
EIN# 57-1206493

WPC 2019

  • 概要 - 日本語
  • About the Congress
    (議会について)
  • WPC Award
    (WPC賞)
  • Committees
    (委員会メンバー)
  • Ambassadors
    (大使)
  • Delegate Leaders
    (リーダーを任命する)
  • Volunteer
    (ボランティア募集)
  • Mobile App
    (モバイルアプリ)
  • Media Inquiries
    (ディアに関するお問い合わせ)
  • Social Media
    (でのソーシャルメディア)
  • WPC in the News
    (ニュースの中のWPC)
  • Promotion
    (昇進)
  • WPC Store
    (WPCストア)
  • FAQs
    (よくある質問)
  • About WPC Inc.
    (WPC Inc.について)
  • Subscribe to eNews
    (ニュースレターを購読する)


  • Program
    (プログラム)

    Registration
    (入校)

    Housing
    (収容)

    Travel
    (旅行)

    Sponsors & Exhibitors
    (スポンサーと出展者)

    © 2015 World Parkinson Coalition Inc.Privacy PolicyDisclaimerContact Us

    Membership Software Powered by YourMembership  ::  Legal